


| Key | % Net Assets |
|---|---|
| 4.6% | |
| 4.0% | |
| 3.2% | |
| 3.1% | |
| 85.1% |
| Name | % Net Assets |
|---|---|
| Merck & Co Inc (New) | 4.6% |
| BP PLC | 4.0% |
| Royal Dutch Shell PLC | 3.2% |
| GlaxoSmithKline PLC | 3.1% |
| British American Tobacco PLC | 2.8% |
| Deutsche Telekom AG | 2.3% |
| Centrica PLC | 2.2% |
| Singapore Tech Engineering Ltd | 2.2% |
| Novartis AG | 2.1% |
| Unilever NV | 2.1% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 280.99p |
| Currency | GBP |
| Change | 0.94p |
| % | 0.34% |
| YTD change | 14.01p |
| YTD % | 5.25% |
| Fund Inception | 30/11/2005 |
|---|---|
| Fund Manager | n/a |
| TER | 1.62 (30-Dec-2011) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.10 |
You are here: research